4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-006702
CHIEF OPERATING OFFICER sold 1,189 shares at $22.03 ($26,194)
- CHIEF OPERATING OFFICER acquired 656 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2024-03-01 | Option exercise 10b5-1 | +656 | $1.59 | $1,043 | 124,036 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2024-03-01 | Sale 10b5-1 | −1,189 | $22.03 | $26,194 | 122,847 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2024-03-01 | Option exercise · Share Option 10b5-1 | −656 | 56,017 | D | ||
| Open-market sales · 1,189 sh · avg $22.03 · $26,194 | |||||||
Loading xslF345X05/form4-03052024_090322.xml…